Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study.
Serra-Burriel M, Juanola A, Serra-Burriel F, Thiele M, Graupera I, Pose E, Pera G, Grgurevic I, Caballeria L, Piano S, van Kleef L, Reichert M, Roulot D, Pericàs JM, Schattenberg JM, Tsochatztis EA, Guha IN, Garcia-Retortillo M, Hernández R, Hoyo J, Fuentes M, Expósito C, Martínez A, Such P, Madir A, Detlefsen S, Tonon M, Martini A, Ma AT, Pich J, Bonfill E, Juan M, Soria A, Carol M, Gratacós-Ginès J, Morillas RM, Toran P, Navarrete JM, Torrejón A, Fournier C, Llorca A, Arslanow A, de Koning HJ, Cucchietti F, Manns M, Newsome PN, Hernáez R, Allen A, Angeli P, de Knegt RJ, Karlsen TH, Galle P, Wong VW, Fabrellas N, Castera L, Krag A, Lammert F, Kamath PS, Ginès P; LiverScreen Consortium Investigators. Serra-Burriel M, et al. Among authors: such p. Lancet. 2023 Sep 16;402(10406):988-996. doi: 10.1016/S0140-6736(23)01174-1. Epub 2023 Aug 9. Lancet. 2023. PMID: 37572680
LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries.
Graupera I, Thiele M, Ma AT, Serra-Burriel M, Pich J, Fabrellas N, Caballeria L, de Knegt RJ, Grgurevic I, Reichert M, Roulot D, Schattenberg JM, Pericas JM, Angeli P, Tsochatzis EA, Guha IN, Garcia-Retortillo M, Morillas RM, Hernández R, Hoyo J, Fuentes M, Madir A, Juanola A, Soria A, Juan M, Carol M, Diaz A, Detlefsen S, Toran P, Pera G, Fournier C, Llorca A, Newsome PN, Manns M, de Koning HJ, Serra-Burriel F, Cucchietti F, Arslanow A, Korenjak M, van Kleef L, Falcó JL, Kamath PS, Karlsen TH, Castera L, Lammert F, Krag A, Ginès P; LiverScreen Consortium investigators. Graupera I, et al. BMC Public Health. 2022 Jul 19;22(1):1385. doi: 10.1186/s12889-022-13724-6. BMC Public Health. 2022. PMID: 35854275 Free PMC article.
Metabolic profiling of night shift work - The HORMONIT study.
Harding BN, Skene DJ, Espinosa A, Middleton B, Castaño-Vinyals G, Papantoniou K, Navarrete JM, Such P, Torrejón A, Kogevinas M, Baker MG. Harding BN, et al. Among authors: such p. Chronobiol Int. 2022 Nov;39(11):1508-1516. doi: 10.1080/07420528.2022.2131562. Epub 2022 Oct 9. Chronobiol Int. 2022. PMID: 36210507 Free PMC article.
Changes in melatonin and sex steroid hormone production among men as a result of rotating night shift work - the HORMONIT study.
Harding BN, Castaño-Vinyals G, Palomar-Cros A, Papantoniou K, Espinosa A, Skene DJ, Middleton B, Gomez-Gomez A, Navarrete JM, Such P, Torrejón A, Kogevinas M, Pozo OJ. Harding BN, et al. Among authors: such p. Scand J Work Environ Health. 2022 Jan 1;48(1):41-51. doi: 10.5271/sjweh.3991. Epub 2021 Oct 8. Scand J Work Environ Health. 2022. PMID: 34623452 Free PMC article.
Plain Language Summary of Publication: A comparison of once-monthly and once-every-2-months injectable formulations of aripiprazole in people with schizophrenia.
Citrome L, Such P, Yildirim M, Madera-McDonough J, Beckham C, Jin N, Watkin S, Zhang Z, Larsen F, Harlin M. Citrome L, et al. Among authors: such p. Ther Adv Psychopharmacol. 2024 Nov 12;14:20451253241286319. doi: 10.1177/20451253241286319. eCollection 2024. Ther Adv Psychopharmacol. 2024. PMID: 39534012 Free PMC article. Review.
Use of an injection of aripiprazole given once every 2 months (Abilify Asimtufii®) in people with bipolar I disorder: a Plain Language Summary of Publication.
McIntyre RS, Such P, Yildirim M, Madera-McDonough J, Jin N, Watkin S, Zhang Z, Larsen F, Harlin M. McIntyre RS, et al. Among authors: such p. Ther Adv Psychopharmacol. 2024 Oct 27;14:20451253241278830. doi: 10.1177/20451253241278830. eCollection 2024. Ther Adv Psychopharmacol. 2024. PMID: 39469110 Free PMC article. Review.
Safety and Efficacy of Aripiprazole 2-Month Ready-to-Use 960 mg: Secondary Analysis of Outcomes in Adult Patients With Schizophrenia in a Randomized, Open-label, Parallel-Arm, Pivotal Study.
Citrome L, Such P, Yildirim M, Madera-McDonough J, Beckham C, Zhang Z, Larsen F, Harlin M. Citrome L, et al. Among authors: such p. J Clin Psychiatry. 2023 Sep 4;84(5):23m14873. doi: 10.4088/JCP.23m14873. J Clin Psychiatry. 2023. PMID: 37672016 Free article. Clinical Trial.
Safety and efficacy of aripiprazole 2-month ready-to-use 960 mg: secondary analysis of outcomes in adult patients with bipolar I disorder in a randomized, open-label, parallel-arm, pivotal study.
McIntyre RS, Such P, Yildirim M, Madera-McDonough J, Zhang Z, Larsen F, Harlin M. McIntyre RS, et al. Among authors: such p. Curr Med Res Opin. 2023 Jul;39(7):1021-1030. doi: 10.1080/03007995.2023.2219155. Epub 2023 Jun 9. Curr Med Res Opin. 2023. PMID: 37272079 Clinical Trial.
A Randomized, Open-Label, Multiple-Dose, Parallel-Arm, Pivotal Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Aripiprazole 2-Month Long-Acting Injectable in Adults With Schizophrenia or Bipolar I Disorder.
Harlin M, Yildirim M, Such P, Madera-McDonough J, Jan M, Jin N, Watkin S, Larsen F. Harlin M, et al. Among authors: such p. CNS Drugs. 2023 Apr;37(4):337-350. doi: 10.1007/s40263-023-00996-8. Epub 2023 Mar 24. CNS Drugs. 2023. PMID: 36961650 Free PMC article. Clinical Trial.
34 results